Results 91 to 100 of about 144,825 (181)

Value-based Healthcare: The Impact of Consolidation in Healthcare on the Field of Orthopaedic Surgery. [PDF]

Clin Orthop Relat Res
Agbafe VC, Bernstein DN, Bozic KJ.
europepmc   +1 more source

The mechanism and impact of digital transformation on supply chain resilience in the manufacturing industry. [PDF]

Sci Rep
Li J, Song H, Ma Y.
europepmc   +1 more source

Implementing digital pathology: qualitative and financial insights from eight leading European laboratories. [PDF]

Virchows Arch
Matias-Guiu X, Temprana-Salvador J, Garcia Lopez P, Kammerer-Jacquet SF, Rioux-Leclercq N, Clark D, Schürch CM, Fend F, Mattern S, Snead D, Fusco N, Guerini-Rocco E, Rojo F, Brevet M, Salto Tellez M, Dei Tos A, di Maio T, Ramírez-Peinado S, Sheppard E, Bannister H, Gkiokas A, Arpaia M, Ben Dhia O, Martino N.   +23 more
europepmc   +1 more source

Analysis of fruquintinib in patients with metastatic colorectal cancer who were enrolled in Spain: results from the global FRESCO-2 study. [PDF]

ESMO Gastrointest Oncol
Garcia-Carbonero R, Elez E, García-Alfonso P, Cubillo Gracían A, López López R, Jimenez-Fonseca P, Limón Mirón ML, Dasari A, Lonardi S, Zhu H, Chen L, Yang Z, Schelman WR, Tabernero J.   +13 more
europepmc   +1 more source

Impact of treatment patterns and sequencing on clinical and economic outcomes in patients with metastatic urothelial cancer: IMPACT UC II study. [PDF]

Oncologist
Bilen MA, Diessner B, White J, Murphy L, Nguyen A, Kirker M, Gharibian N, Morris V, Bhanegaonkar A.   +8 more
europepmc   +1 more source

Environmental sustainability in veterinary clinics: best practices for the United States and Canada. [PDF]

Front Vet Sci
Kern-Allely C, Scott D, Clow K, Duncan C.   +3 more
europepmc   +1 more source

Biomarker analyses from the phase III randomized CLEAR trial: lenvatinib plus pembrolizumab versus sunitinib in advanced renal cell carcinoma. [PDF]

Ann Oncol
Motzer RJ, Porta C, Eto M, Hutson TE, Rha SY, Merchan JR, Winquist E, Gurney H, Grünwald V, George S, Markensohn J, Burgents JE, Cristescu R, Sachdev P, Narita Y, Huang J, Zhao Z, Okpara CE, Minoshima Y, Choueiri TK.   +19 more
europepmc   +1 more source

Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor-Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321). [PDF]

J Clin Oncol
Sharman JP, Munir T, Grosicki S, Roeker LE, Burke JM, Chen CI, Grzasko N, Follows G, Mátrai Z, Sanna A, Qiu L, Feng R, Hua VM, Jurczak W, Ritgen M, Yi S, Bosch F, Coombs CC, Bao K, Patel V, Liu B, Compte L, Guntur A, Wang DY, Hill M, Leow CC, Ghia P, Barr PM.   +27 more
europepmc   +1 more source

Taxing the Income of the Close Corporation [PDF]

, 1953
Lowndes, Charles L. B.
core   +2 more sources

Health Disparities in Acute Myeloid Leukemia Patients Undergoing Treatment with Tyrosine Kinase Inhibitor (TKI) Therapy Targeting FLT3, IDH1, or IDH2. [PDF]

Blood Lymphat Cancer
Espinoza-Gutarra MR, Jarrett BA, Wang X, Afghahi A, Bae S.   +4 more
europepmc   +1 more source